For research use only. Not for therapeutic Use.
KWAR 23(Cat No.:I043208)is an experimental small molecule compound being studied for its potential therapeutic effects in cancer treatment. It functions by targeting specific proteins involved in cancer cell survival, growth, and metastasis, with the goal of inhibiting tumor progression. KWAR 23 is under investigation in preclinical and clinical trials to evaluate its safety, efficacy, and mechanisms of action. Its development is focused on enhancing targeted therapies for various cancers, offering a promising approach to overcoming resistance mechanisms and improving patient outcomes in oncology treatments.
CAS Number | 2243227-60-1 |
Purity | ≥95% |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |